Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 3, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Hives (see also 'Skin'); Itching; Bad taste | Recovered/Normal |
| Nov 1, 2017 | Human | Unknown | Trilostane | Generalised rash; Accidental exposure | Outcome Unknown |
| Nov 1, 2017 | Human | Unknown | Toceranib Phosphate | Pigmentation disorder | Outcome Unknown |
| Nov 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Respiratory tract irritation; Dizziness; Shaking | Recovered/Normal |
| Nov 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Tingling skin; Eye irritation; Nasal congestion; Swollen lip (see also 'Skin') | Ongoing |
| Oct 31, 2017 | Human | Unknown | Oxytetracycline Dihydrate (Oxytetracy... | Injection site lesion; Injection site reaction NOS | Outcome Unknown |
| Oct 31, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Vision blurred; Eye irritation; Stomach pain; Tachycardia; Irregular breathin... | Outcome Unknown |
| Oct 30, 2017 | Human | Unknown | Tilmicosin | Bad taste; Dizziness; Tingling sensation; Malaise; High blood pressure; Accid... | Ongoing |
| Oct 30, 2017 | Human | Unknown | Fluralaner Chew Tablets | Malaise | Outcome Unknown |
| Oct 29, 2017 | Human | Unknown | Moxidectin | Pruritic rash; Application site rash; Application site pruritus | Outcome Unknown |
| Oct 26, 2017 | Human | Unknown | Oclacitinib Maleate | Pruritus; Erythema (for urticaria see Immune SOC) | Outcome Unknown |
| Oct 26, 2017 | Human | Unknown | Tulathromycin | Injection site pain; Injection site reaction NOS | Outcome Unknown |
| Oct 26, 2017 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Immediate pain upon injection; Injection site inflammation; Injection site oe... | Recovered/Normal |
| Oct 26, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Oct 24, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Oct 23, 2017 | Human | Unknown | Flunixin Meglumine | Eye irritation; Swelling around eye; Accidental exposure | Recovered/Normal |
| Oct 23, 2017 | Human | Unknown | Tiletamine Hcl; Zolazapam Hcl | Numbness; Dizziness; Injection site reaction NOS; Injection site bleeding | Recovered/Normal |
| Oct 20, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Oct 19, 2017 | Human | Unknown | Praziquantel; Emodepside | Hyperaemic mucous membrane; Swollen tongue; Anaphylactic-type reaction | Recovered/Normal |
| Oct 19, 2017 | Human | Unknown | Praziquantel; Emodepside | Stomach pain; Accidental drug intake by child; Accidental exposure | Outcome Unknown |
| Oct 18, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Increased heart rate; Difficulty sleeping; Application site skin change NOS; ... | Ongoing |
| Oct 17, 2017 | Human | Unknown | Enrofloxacin | Injection site pain; Light headedness; Accidental exposure | Recovered/Normal |
| Oct 17, 2017 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation | Recovered/Normal |
| Oct 12, 2017 | Human | Unknown | Tildipirosin Injectable | Injection site pain | Ongoing |
| Oct 12, 2017 | Human | Unknown | Florfenicol/Flunixin Inj-Triac | Injection site swelling | Recovered/Normal |
| Oct 11, 2017 | Human | Unknown | Praziquantel; Emodepside | Burning sensation (skin); Accidental exposure | Outcome Unknown |
| Oct 11, 2017 | Human | Unknown | Tilmicosin | Injection site bleeding; Accidental exposure | Ongoing |
| Oct 11, 2017 | Human | Unknown | Praziquantel; Emodepside | Burning sensation (skin); Erythematous rash; Numbness; Pruritus; Tongue parae... | Outcome Unknown |
| Oct 11, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Dispenser, Abnormal | Recovered/Normal |
| Oct 10, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Product label issues | Recovered/Normal |
| Oct 8, 2017 | Human | Unknown | Itraconazole | Eye disorder NOS (for photophobia see 'neurological') | Recovered/Normal |
| Oct 7, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Tingling sensation; Itchy skin | Recovered/Normal |
| Oct 6, 2017 | Human | Unknown | Oclacitinib Maleate | Vomiting; Accidental exposure | Outcome Unknown |
| Oct 6, 2017 | Human | Unknown | Nitenpyram | Stomach upset; Accidental exposure | Ongoing |
| Oct 5, 2017 | Human | Unknown | Ivermectin; Clorsulon | Bad taste; Accidental exposure | Recovered/Normal |
| Oct 4, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Oct 4, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Diarrhoea; Accidental exposure | Recovered/Normal |
| Oct 4, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Oct 4, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Vials, Leaking; Vials, Abnormal | Ongoing |
| Oct 3, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Oct 2, 2017 | Human | Unknown | Ivermectin | Burning sensation of eye; Vision blurred; Accidental exposure | Outcome Unknown |
| Oct 2, 2017 | Human | Unknown | Selamectin | Heavy sweating; Accidental exposure | Recovered/Normal |
| Oct 2, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site pain | Recovered/Normal |
| Oct 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Product label issues | Recovered/Normal |
| Sep 30, 2017 | Human | Unknown | Selamectin | Seizure NOS; Aphasia; Accidental exposure | Ongoing |
| Sep 28, 2017 | Human | Unknown | Isoflurane | Burning sensation of eye | Recovered/Normal |
| Sep 27, 2017 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Ocular burn; Eye redness | Recovered/Normal |
| Sep 26, 2017 | Human | Unknown | Selamectin | Mouth irritation | Outcome Unknown |
| Sep 25, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal | Ongoing |
| Sep 24, 2017 | Human | Unknown | Florfenicol/Flunixin Inj-Triac | Injection site pain | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.